Answers are grounded in this paper and cite their sources.
Asia contains over 60% of the global population and vast genetic diversity, yet its genomic resources remain underrepresented. Over the past decade or so, regional research has evolved from fragmented surveys into large-scale national precision medicine initiatives. Here, we examine how these sequencing efforts collectively form an emerging Asian genomic infrastructure. We discuss future directions to close critical gaps in Central Asia, minority populations, cross-project interoperability, and equitable access, highlighting the transition toward interoperable, clinical-grade genomic ecosystems supporting precision medicine across the continent.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: